Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom's Macroglobulinemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02604511
What this trial is testing

Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT01614821
What this trial is testing

Ibrutinib (PCI-32765) in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492050
What this trial is testing

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT04463953
What this trial is testing

Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Ended earlyNCT03679624
What this trial is testing

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; Hypergammaglobulinemia+4 more
Weill Medical College of Cornell University 1
Testing effectiveness (Phase 2)Ended earlyNCT00142168
What this trial is testing

CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 16
Early research (Phase 1)Ended earlyNCT01078974
What this trial is testing

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Steven P. Treon, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT00004107
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 18
Testing effectiveness (Phase 2)Study completedNCT00005609
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT02142530
What this trial is testing

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

Who this might be right for
Non-Hodgkin LymphomaDiffuse Large B-cell LymphomaMantle Cell Lymphoma+2 more
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT00165295
What this trial is testing

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 30
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Testing effectiveness (Phase 2)Study completedNCT04440059
What this trial is testing

ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia Refractory
Beijing InnoCare Pharma Tech Co., Ltd. 47
Testing effectiveness (Phase 2)Ended earlyNCT00107614
What this trial is testing

DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients

Who this might be right for
Waldenstrom Macroglobulinemia
University of Arkansas 12
Testing effectiveness (Phase 2)Study completedNCT01046006
What this trial is testing

Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Meletios A. Dimopoulos 59
Testing effectiveness (Phase 2)UnknownNCT02971982
What this trial is testing

PCD Versus RCD for the Treatment of Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Treatment
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Study completedNCT00004889
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)WithdrawnNCT00081068
What this trial is testing

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03335098
What this trial is testing

Study of VTD in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaLymphoplasmacytic Lymphoma
Seoul National University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02363439
What this trial is testing

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 5
Next Page